Information, not a decision

Neuroblastoma: tumour board sheet

Dated public registry data. It contains no treatment recommendation. 12 Nov 2026

Open trials (132)

NCT04936529	Phase 2	A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma	Recruiting
NCT07527169	Phase 2	A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma	Recruiting
NCT06804447	No phase	Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal Neuroblastoma	Recruiting
NCT06057948	Phase 2	A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma	Recruiting
NCT06041516	Phase 1	A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors	Recruiting
NCT04903899	Phase 2	177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma	Recruiting
NCT07437963	Phase 1/2	Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse	Recruiting
NCT06176989	Phase 2	Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors	Recruiting
NCT04837547	Phase 1	PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy	Recruiting
NCT07549321	Phase 2/3	A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients	Recruiting
NCT07897968	Phase 1	GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors	Not yet recruiting
NCT06942039	Early Phase 1	Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation	Recruiting

120 more in the doctor's list on the site.

NCT04724369

30 Aug 2026

Completed

Links only: read the guideline itself.

Made from the public data of Frontlight Research. Source: ClinicalTrials.gov. 12 Nov 2026

https://frontlightresearch.com/en/doctor/neuroblastoma/tumor-board